ACET ADICET BIO INC US FDA Inspections 8-K Filing 2024 - Clinical Trial Update Adicet Bio, Inc. announced the opening of enrollment for its Phase 1 clinical trial of ADI-001 targeting autoimmune diseases, with plans to report preliminary data in early 2025.Get access to all SEC 8-K filings of the ADICET BIO INC